Advertise with us
Clinical Group

International Journal of Clinical Endocrinology and Metabolism



Abstract Open Access
Editorial PTZAID: IJCEM-3-123

A Rare Entity Pituitary FDG Uptake; What Should We Expect?

Zehra Pınar Koç*, Pelin Özcan Kara and Emel Sezer

F-18  fluorodeoxyglucos  (FDG)  positron emission tomography/computed tomography (PET/CT)  is widely accepted modality in order to evaluate the cancer patients for staging, restaging  and  treatment  response evaluation.The increasing trend towards application of this modality and growing number of cancer patient population concluded by increased   number of  FDG  PET/CT studies performed. Incidental detection of various importan findings unrelated to the first  disease  presentation is inevitable and frequent than expected. These findings contribute significant gain in patient management and sometimes prevent second  malignancies.One of these secondary findings is incidental pituitary FDG uptake which is a  rare situation. The clinical significance of this entity is not well established. This finding may represent malignant involvement rarely or benign causes like pituitary adenoma.

Published on: Jul 5, 2017 Pages: 16-17

Full Text PDF Full Text HTML DOI: 10.17352/ijcem.000023